Patients are seen by pulmonologists who work in close collaboration with specialists in allergy and immunology, otolaryngology, gastroenterology, chest radiologists, thoracic surgeons, diagnostic radiologists, cardiothoracic surgeons and pulmonary pathologists to provide definitive diagnoses and therapeutic options across the spectrum of pulmonary medicine.
Besides tuberculosis care, Winchester Chest Clinic currently serves a broader role in all facets of chest diseases through the services of its centers and programs. The clinic's programs and services include:
- Adult Cystic Fibrosis (CF) Program. CF was previously considered to be a childhood disease, but with improving nutritional and other medical support, the median survival of CF patients is now 32 years and rising. Because pulmonary disease remains the primary cause of morbidity and mortality for these patients, however, this program works to transition pediatric CF patients to adult inpatient and outpatient care.
Our CF Center is the larger of two adult CF programs accredited by the CF Foundation in Connecticut. The center offers comprehensive clinical care for the problems affecting CF patients, including pulmonary disease, sinus disease, pancreatic insufficiency and malabsorption, malnutrition, CF-related liver disease, CF-related diabetes and osteoporosis. Post-transplant patients are also followed for surveillance and treatment of transplant-related complications. The multidisciplinary team includes CF-trained nurses, respiratory therapists, physical therapists, dietitians, social workers and physicians.
- Yale Center for Asthma and Airways Disease (YCAAD) is an established referral source throughout southern New England for patients suffering from asthma and airway disease. YCAAD provides comprehensive, multidisciplinary treatment to a broad spectrum of asthmatics, including patients with difficult-to-control asthma or chronic cough, those who are diagnostic dilemmas and those who may be significantly affected by co-morbid illnesses, such as gastroesophageal reflux disease (GERD), sinusitis, vocal cord dysfunction and atopy. YCAAD researchers are currently involved in developing an innovative bronchial thermoplasty procedure for asthma patients.
YCAAD specialists work closely with colleagues in allergy and immunology, otolaryngology, gastroenterology, and occupational and environmental medicine. Furthermore, the Center treats a broad base of patients with chronic obstructive pulmonary disease (COPD), ranging from those with mild symptoms to those in need of rehabilitation or assisted ventilation, or who are being considered for lung-volume- reduction surgery or lung transplantation.
In addition to providing state-of-the-art clinical care, YCAAD is a hub of human research in airway disease, where both industry-sponsored and investigator- initiated studies are continually underway.
- The Interstitial Lung Disease (ILD) Center diagnoses and treats a group of often-difficult-to-diagnose lung disorders that can produce inflammation and/or scarring in the lungs, including idiopathic pulmonary fibrosis, sarcoidosis, asbestosis, silicosis, non-specific interstitial pneumonia and bronchiolitis. This center closely collaborates with pulmonary pathology, radiology and rheumatology to deliver optimal ILD care.
The evaluation of patients with ILD includes an assessment for causes, such as occupational and environmental exposures, autoimmune diseases, drug exposures and hereditary diseases. Treatment may include immunosuppressive or antifibrotic therapy. For patients with severe disease, cutting-edge clinical trials of new therapeutic approaches and medications are offered. The ILD Center is one of 22 Centers of Excellence in the National Institutes of Health (NIH)-sponsored IPFNet. The center also conducts research on the mechanisms of pulmonary fibrosis.
- The Pulmonary Vascular Diseases Center addresses the complex needs of patients with this disease. The center collaborates with YNHH's departments of cardiology, rheumatology and hematology and the liver transplant program. In addition, the center has dovetailed its expertise with the Adult Congenital Heart Disease Program and the Hereditary Hemorrhagic Telangiectasia Program, and conducts clinical research related to pulmonary arterial hypertension.
- Tuberculosis Center. Our outpatient Tuberculosis Center is the regional referral center for tuberculosis. The physicians includes several Yale School of Medicine faculty members who are nationally recognized for their expertise in the field. The long history of chest medicine at Winchester Chest Clinic reflects its original mission as a center for tuberculosis care.
Many patients also come to Winchester Chest Clinic with work-related pulmonary disease and sleep disorders. Often, patients come to the Clinic without a diagnosis, but with symptoms such as persistent or nagging cough, shortness of breath at rest or with exertion. We evaluate difficult or unusual problems by drawing upon the expertise of clinical specialists in other disciplines as well as on the extensive library at Yale School of Medicine.
Winchester Chest Clinic appointments are made by physician referral. The physician should refer their patient for evaluation by a pulmonary specialist. Referrals for tuberculosis may be made by physician, health department, or patient self-referral.
For more information about Winchester Chest Clinic, please call 203.785.4198.
History of Winchester Chest Clinic
The history of Winchester Chest Clinic dates back to the early 1900s, to a bequest by Sarah Winchester, who established an endowment in memory of her husband William Wirt Winchester (of the New Haven-based Winchester Repeating Arms Company, famous for its Winchester rifle), and their young daughter, both of whom succumbed to tuberculosis. This resulted in the establishment of the original Winchester Hospital in West Haven, dedicated to the care of tuberculosis patients. That facility evolved from a freestanding unit to become part of YNHH, yet always with the mission of tuberculosis treatment and research - a tradition that proudly continues at Winchester's Tuberculosis Center.